A Study of Galantamine Used to Treat Patients With Mild to Moderate Alzheimer’s Disease
Condition(s):Alzheimer’s DiseaseLast Updated:September 19, 2013Terminated
Hide Studies Not Open or Pending
Condition(s):Alzheimer’s DiseaseLast Updated:September 19, 2013Terminated
Condition(s):Frontotemporal Dementia; Pick ComplexLast Updated:June 8, 2011Completed
Condition(s):Schizophrenia; Schizoaffective DisorderLast Updated:December 16, 2020Completed
Condition(s):Basic Science Study of the Mechanisms of Attentional Enhancement by Compounds Acting on the Nicotinic ReceptorLast Updated:November 4, 2019Completed
Condition(s):Alzheimer DiseaseLast Updated:June 8, 2011Completed
Condition(s):Dementia; Alzheimer Disease; Dementia, VascularLast Updated:June 18, 2014Completed
Condition(s):DementiaLast Updated:August 26, 2013Completed
Condition(s):Alzheimer’s DiseaseLast Updated:April 17, 2014Completed
Condition(s):Alzheimer DiseaseLast Updated:March 26, 2012Completed
Condition(s):Alzheimer’s DiseaseLast Updated:July 8, 2014Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.